Skip to content

Teletechnology-assisted Home-based Exercise Program for Severe COVID-19

Efficacy of Teletechnology-assisted Home-based Exercise Program for Severe COVID-19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05778344
Enrollment
20
Registered
2023-03-21
Start date
2023-04-12
Completion date
2024-05-24
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Telerehabilitation

Keywords

Pulmonary Rehabilitation

Brief summary

The aim of this study was to investigate the efficacy of a home-based pulmonary rehabilitation program with the support of teletechnology in COVID-19 survivors. The main questions it aims to answer were: * The change of six-minute walk distance * The change of time of one-minute sit-to-stand test * The change of maximal strength of upper-limb, lower-limb and respiratory muscle * The change of quality of life Participants in the home-based pulmonary rehabilitation group received teletechnology-assisted consultations (either by videotelephony or telephone calls) for every 1-2 weeks during the intervention period, and participants in the usual care group did not receive teletechnology-assisted consultations during the intervention period.

Interventions

BEHAVIORALTeletechnology-assisted home-based pulmonary rehabilitation

The accuracy and safety of home-based pulmonary rehabilitation will be checked regularly through technology devices such as smart watch and via videotelephony (or telephone calls if indicated).

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients are 20 years or more with severe (severe pneumonia) to critical (acute respiratory distress syndrome, sepsis, or septic shock) COVID-19 during hospitalization after deisolation. * Patients are 65 years or more, or ever receiving oral antiviral treatment after deisolation. * Patient have the ability to ambulate on level surface without direct contact of another person, have telecommunication device(s), and provide consent to receive teletechnology-assisted rehabilitation.

Exclusion criteria

* Patients are pregnant or planning for pregnancy. * Patients have cognitive dysfunction, learning disability, uncontrolled arrhythmia or hypertension, or any medical diagnosis other than COVID-19 that would prominently influence their ability to follow instructions and perform exercise.

Design outcomes

Primary

MeasureTime frameDescription
Six-minute walk distanceWeek 0The distance of six-minute walk test

Secondary

MeasureTime frameDescription
Maximal upper limb strengthWeek 0Hand grip strength
Maximal lower limb strengthWeek 0Leg press strength
Maximal respiratory muscle strengthWeek 0Inspiratory and expiratory pressure of respiratory muscle
Quality of life scoreWeek 0Quality of life assessed by Short-form 12 questionnaire

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026